NEO peer analysis
NeoGenomics (NEO) against its competitors: price, today's move, 1-year return and market value side by side.
NEO and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDSX Biodesix | $23.25 | -5.93% | 253.96% | – |
| CSTL Castle Biosciences | $34.95 | -5.95% | 44.36% | $1.14B |
| FRNM Freenome | $12.48 | -2.95% | – | – |
| GH Guardant Health | $170.75 | -4.50% | 84.77% | $23.99B |
| GRAL GRAIL | $133.60 | -6.85% | 56.79% | – |
| MYGN Myriad Genetics | $5.83 | -8.27% | -26.73% | $607.38M |
| PSNL Personalis | $15.77 | -0.32% | 65.83% | $1.69B |
| VCYT Veracyte | $49.07 | -1.88% | 38.89% | $4.02B |
| WGS GeneDx | $64.11 | -7.17% | -51.25% | $2.06B |
| XGN Exagen | $8.59 | -1.26% | -26.96% | $208.10M |
| NEO NeoGenomics | $16.49 | -5.12% | 70.18% | $2.25B |
- NEO's peers: BDSX (Biodesix), CSTL (Castle Biosciences), FRNM (Freenome), GH (Guardant Health), GRAL (GRAIL), MYGN (Myriad Genetics), PSNL (Personalis), VCYT (Veracyte).
Updated 2026-11-03 00:47 UTC